Press releases
- Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
- Pulse Biosciences Announces Plans to Initiate a Rights Offering
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
- Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
- Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
More ▼
Key statistics
On Tuesday, Pulse Biosciences Inc (6L8:DUS) closed at 7.15, 16.26% above the 52 week low of 6.15 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.70 |
---|---|
High | 7.15 |
Low | 6.65 |
Bid | 6.85 |
Offer | 6.95 |
Previous close | 6.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 55.23m |
Free float | 16.36m |
P/E (TTM) | -- |
Market cap | 400.38m USD |
EPS (TTM) | -0.8936 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 18:32 BST.
More ▼